DETERMINANTS OF PARTICIPATION SURVIVORS COVID-19 AMONG ≥45 YEARS OLD TO COVID-19 THIRD DOSE VACCINATION
Determinan Partisipasi Penyintas COVID-19 Berusia ≥ 45 Tahun dalam Vaksinasi COVID-19 Dosis 3
Downloads
Background: Booster vaccinations are a way to keep the body protected against COVID-19. Mojolangu Health Center is one of the densely populated areas which is part of the Lowokwaru sub-district and borders the Belimbing sub-district; the two sub-districts are ranked 2nd and 1st with the highest CFR (Case Fatality Rate) in Malang City. Therefore, examining public perceptions of vaccination to evaluate immunization programs and raise performance goals is essential. Purpose: To determine the relationship between the Health Belief Model components (perceived susceptibility, severity, benefits, barrier, and cues to action) and the participation of COVID-19 booster vaccination in survivors of COVID-19 aged ≥45 years. Conducted from April to November 2022, this research was located in the working area of Mojolangu Health Center (Mojolangu, Tunjungsekar, Tunggulwulung, and Tasikmadu village). Methods: This quantitative research used a case-control design study. This research sample comprised 82 people, selected using the purposive sampling technique with a 1:1 ratio for case and control. Data analysis was done using the Chi-Square test and Binary Logistics Regression tests. Results: The respondents were dominated by the middle age group (45-59 years), primarily entrepreneurs with a monthly income of more than IDR 3.5 million and domiciled in Mojolangu village. The perceived benefits variable showed p=0.04 (aOR=2.67; 95% CI=1.03-6.91) and perceived barriers p=0.01 (aOR=3.60; 95% CI=1.39-9.28), while perceived vulnerability p=1.00 (cOR=1.00; 95% CI= 0.32 – 3.16), perception of cues to act p= 0.18 (cOR= 1.82; 95% CI= 0.75 - 4.40). Conclusion: Factors related to booster vaccination participation are perceived benefits and barriers.
World Health Organization. Statement on the antigen composition of COVID-19 vaccines [Internet]. World Health Organization. 2024. Available from: https://www.who.int/news/item/26-04-2024-statement-on-the-antigen-composition-of-covid-19-vaccines
Afni N, Rahayu S. Analysis of Risk Factors for Death of Covid-19 Patients at Undata Hospital Palu. J Public Heal Pharm. 2022;2(2):24–9.
Kunoli FJ, Rahayu S. Analisis Faktor Risiko Kematian Pasien Covid-19 Di Rsud Undata Palu. J Ilmu Kesehat. 2022;16(2):249–55.
Hansen CH, Michlmayr D, Gubbels SM, Mí¸lbak K, Ethelberg S. Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study. Lancet. 2021;397(10280):1204–12.
Kementerian Kesehatan Republik Indonesia. Vaksinasi COVID-19 Nasional: Data per Tanggal 22 Maret 2022 Pukul 18.00 WIB [Internet]. 2022 [cited 2022 Mar 23]. Available from: https://vaksin.kemkes.go.id/#/vaccines
Widyawati. Vaksinasi Dosis 2 Telah Mencapai 70,38% dari Target Sasaran Vaksinasi Nasional – Sehat Negeriku [Internet]. Kementerian Kesehatan Republik Indonesia . 2022 [cited 2022 Apr 6]. Available from: https://sehatnegeriku.kemkes.go.id/baca/rilis-media/20220304/0239463/vaksinasi-dosis-2-telah-mencapai-7038-dari-target-sasaran-vaksinasi-nasional/
SATGAS COVID-19 JATIM. JATIM TANGGAP COVID-19 [Internet]. 2022 [cited 2022 Mar 23]. Available from: https://infocovid19.jatimprov.go.id/#peta
Thompson MG, Natarajan K, Irving SA, Rowley EA. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19 – Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance ” VISION Network, 10 States, August 202. Morb Mortal Wkly Report US Dep Heal Hum Serv CDC [Internet]. 2022;71(4):139–45. Available from: https://www.cdc.gov/mmwr/volumes/71/wr/mm7104e3.htm#suggestedcitation
Zhuang C, Liu X, Chen Q, Sun Y, Su Y, Huang S, et al. Protection Duration of COVID-19 Vaccines: Waning Effectiveness and Future Perspective. Front Microbiol. 2022;13(828806):1–7.
Gunarni S, Aziz A. Hubungan Persepsi Health Belief Model Dengan Perilaku Hand Hygiene Dalam Mencegah Transmisi COVID-19 Pada Keluarga Pasien Di Instalasi Rawat Inap Rumah Sakit Dustira TK.II 03.05.01 Cimahi. Syntax Lit J Ilm Indones [Internet]. 2022;7(2):2403–25. Available from: https://www.jurnal.syntaxliterate.co.id/index.php/syntax-literate/article/view/6240
Wang YL, Cheng ST, Shen CF, Huang SW, Cheng CM. Impact of the COVID-19 vaccine booster strategy on vaccine protection: a pilot study of a military hospital in Taiwan. Clin Exp Vaccine Res. 2023;12(4):337–45.
Camacho-neciosup R, Balcazar-huaman EN, Margarita L. Factors associated with intention to be vaccinated with the COVID-19 booster dose : a cross-sectional study in Peru. PeerJ. 2024;12:1–26.
Albtoosh AS, Farah R, Al K, Mohammad O, Ahmad A, Mounir H, et al. Presenting clinical symptoms of post-COVID-19 breakthrough infection : Predictors of mortality in a Middle Eastern population. Vaccine X. 2024;18(100495):1–5.
Lin Y, Hu Z, Zhao Q, Alias H, Danaee M, Wong LP. Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China. PLoS Negl Trop Dis [Internet]. 2020;14(12:e0008961):1–22. Available from: http://dx.doi.org/10.1371/journal.pntd.0008961
Wu F, Yuan Y, Deng Z, Yin D, Shen Q, Zeng J, et al. Acceptance of COVID-19 booster vaccination based on the protection motivation theory: A cross-sectional study in China. J Med Virol. 2022;94(9):4115–24.
Wirawan GBS, Harjana NPA, Nugrahani NW, Januraga PP. Health Beliefs and Socioeconomic Determinants of COVID-19 Booster Vaccine Acceptance : An Indonesian Cross-Sectional Study. Vaccines. 2022;10(724):1–14.
Han MFY, Mahendran R, Yu J. Associations Between Fear of COVID-19, Affective Symptoms and Risk Perception Among Community-Dwelling Older Adults During a COVID-19 Lockdown. Front Psychol. 2021;12(March:Article 638831):1–10.
Rosyidi. Peran Komunikasi Massa di Tengah Pandemi COVID-19. HUDAN LIN-NAAS J Ilmu Sos dan Hum [Internet]. 2021;2(1):45–58. Available from: http://ejournal.idia.ac.id/index.php/hudanlinnaas/inde x
Wang H, Huang Y-M, Su X-Y, Xiao W-J, Si M-Y, Wang W-J, et al. Acceptance of the COVID-19 vaccine based on the health belief model: a multicenter national survey among medical care workers in China. Hum Vaccin Immunother. 2022;(May):1–11.
Okmi EA, Almohammadi E, Alaamri O, Alfawaz R, Alomari N, Marwah, et al. Determinants of COVID-19 Vaccine Acceptance Among the General Adult Population in Saudi Arabia Based on the Health Belief Model : A Web- Based Cross-Sectional Study. Cureus. 2022;14(8:e28326):1–16.
Qin C, Wang R, Tao L, Liu M, Liu J. Acceptance of a Third Dose of COVID-19 Vaccine and Associated Factors in China Based on Health Belief Model: A National Cross-Sectional Study. Vaccines. 2022;10(1):89.
Sukri, Taliabo P, Wardani W. Hubungan Tingkat Pendidikan dan Persepsi Masyarakat Terhadap Perilaku Pencegahan COVID-19 di Dusun Dabo Desa Sipatuo Kecamatan Patampanua Kabupaten Pinrang. J Kesehat Lentera Acitya [Internet]. 2021;8(2):69–75. Available from: http://www.lppmfatimaparepare.org/index.php/acitya/issue/view/Vol. 8 No. 2 Desember 2021
Rachmawati WC. Promosi Kesehatan dan Ilmu Perilaku. Malang: Wineka Media; 2019.
Klugar M, Riad A, Mohanan L, Pokorná A. COVID-19 Vaccine Booster Hesitancy (VBH) of Healthcare workers in Czechia: National Cross-Sectional Study. Vaccines. 2021;9(12):1–29.
Ghazy RM, Abdou MS, Awaidy S, Sallam M, Elbarazi I. Acceptance of COVID-19 Vaccine Booster Doses Using the Health Belief Model : A Cross-Sectional Study in Low-Middle- and High-Income Countries of the East Mediterranean Region. Int J Environ Res Public Health. 2022;19(12136):1–16.
Elgendy MO, El-Gendy AO, Mahmoud S, Mohammed TY, Abdelrahim MEA, Sayed AM. Side Effects and Efficacy of COVID-19 Vaccines among the Egyptian Population. Vaccines. 2022;10(1):109.
Hu D, Liu Z, Gong L, Kong Y, Liu H, Wei C, et al. Exploring the Willingness of the COVID-19 Vaccine Booster Shots in China Using the Health Belief Model: Web-Based Online Cross-Sectional Study. Vaccines. 2022;10(8):1336.
Qin C, Yan W, Tao L, Liu M, Liu J. The Association between Risk Perception and Hesitancy toward the Booster Dose of COVID-19 Vaccine among People Aged 60 Years and Older in China. Vaccines. 2022;10(7):1112.
Kyaw TM, Al Kurrummiah B, Ap Varathappan N, Ap Rathanam DT, Ap Ravindran S, Al Sasidharan G, et al. Factors Influencing the Acceptance of COVID-19 Booster Dose in Malaysia. J Educ Community Heal. 2022;9(2):69–79.
Ao Q, Egolet RO, Yin H, Cui F. Acceptance of COVID-19 Vaccines among Adults in Lilongwe, Malawi: A Cross-Sectional Study Based on the Health Belief Model. Vaccines. 2022;10(5:760):1–21.
- Every manuscript submitted to must observe the policy and terms set by the Jurnal Berkala Epidemiologi
- Publication rights to manuscript content published by the Jurnal Berkala Epidemiologi is owned by the journal with the consent and approval of the author(s) concerned. (download copyright agreement)
- Complete texts of electronically published manuscripts can be accessed free of charge if used for educational and research purposes according to copyright regulations.
JBE by Universitas Airlangga is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
